BioCentury | Apr 11, 2020
Emerging Company Profile

Clover: trimerizing fusion proteins

...least four other companies, including AbbVie Inc. (NYSE:ABBV), Apogenix AG, Genmab A/S (CSE:GMAB; NASDAQ:GMAB) and Theraly Fibrosis Inc....
BioCentury | Aug 14, 2019
Financial News

D&D raises $137M to fund inflammation tech out of JHU

...in-licensed from Johns Hopkins University. The funds will be split between three D&D family companies: Theraly Fibrosis Inc....
...Tumor necrosis factor receptor superfamily member 10b Elizabeth S. Eaton, Staff Writer D&D Pharmatech Co. Ltd. Neuraly Inc. Theraly Fibrosis Inc. Glucagon-like...
BioCentury | Apr 25, 2019
Finance

The academic founders' conundrum

...brought on co-founder and fellow Johns Hopkins professor Seulki Lee, who founded Baltimore-based fibrosis company Theraly Fibrosis Inc....
...Diego, Calif. Stanford University, Stanford, Calif. Stimunity S.A.S., Paris, France Storm Therapeutics Ltd., Cambridge, U.K. Theraly Fibrosis Inc....
BioCentury | Mar 19, 2019
Distillery Therapeutics

Agonizing TNFRSF10B for scleroderma

...steps could include testing TNFRSF10B agonists in combination with other antifibrotic agents in the models. Theraly Fibrosis Inc....
...CONTACT: Seulki Lee, Johns Hopkins University School of Medicine, Baltimore, Md. email: seulki@jhmi.edu Claire Quang Johns Hopkins University Theraly Fibrosis Inc. Tumor...
Items per page:
1 - 4 of 4
BioCentury | Apr 11, 2020
Emerging Company Profile

Clover: trimerizing fusion proteins

...least four other companies, including AbbVie Inc. (NYSE:ABBV), Apogenix AG, Genmab A/S (CSE:GMAB; NASDAQ:GMAB) and Theraly Fibrosis Inc....
BioCentury | Aug 14, 2019
Financial News

D&D raises $137M to fund inflammation tech out of JHU

...in-licensed from Johns Hopkins University. The funds will be split between three D&D family companies: Theraly Fibrosis Inc....
...Tumor necrosis factor receptor superfamily member 10b Elizabeth S. Eaton, Staff Writer D&D Pharmatech Co. Ltd. Neuraly Inc. Theraly Fibrosis Inc. Glucagon-like...
BioCentury | Apr 25, 2019
Finance

The academic founders' conundrum

...brought on co-founder and fellow Johns Hopkins professor Seulki Lee, who founded Baltimore-based fibrosis company Theraly Fibrosis Inc....
...Diego, Calif. Stanford University, Stanford, Calif. Stimunity S.A.S., Paris, France Storm Therapeutics Ltd., Cambridge, U.K. Theraly Fibrosis Inc....
BioCentury | Mar 19, 2019
Distillery Therapeutics

Agonizing TNFRSF10B for scleroderma

...steps could include testing TNFRSF10B agonists in combination with other antifibrotic agents in the models. Theraly Fibrosis Inc....
...CONTACT: Seulki Lee, Johns Hopkins University School of Medicine, Baltimore, Md. email: seulki@jhmi.edu Claire Quang Johns Hopkins University Theraly Fibrosis Inc. Tumor...
Items per page:
1 - 4 of 4